Our Services

Comprehensive biopharmaceutical consulting across the full drug development continuum — from discovery to market.

Drug Hunting

Navigation of the current and future pipeline of top biopharmaceutical companies with smart due diligence and investor-backed acquisition.

Comprehensive consulting for Antibody-Drug Conjugate development from target selection through clinical development and regulatory approval.

Expert guidance in immuno-oncology discovery and development, leveraging the latest scientific knowledge in cancer immunotherapy.

Strategic support for early-stage drug discovery programs, target identification, and lead optimization across multiple modalities.

Full-spectrum preclinical development consulting including toxicology, pharmacology, ADME, and IND-enabling studies.

Clinical strategy, trial design, protocol development, and regulatory interface for Phase I through Phase III programs.

Chemistry, Manufacturing, and Controls consulting for biologics and small molecules, from process development to commercial manufacturing.

Bridging the gap between preclinical findings and clinical outcomes through biomarker strategy, PK/PD modeling, and translational medicine.

Regulatory strategy and submission support for INDs, BLAs, NDAs, and global regulatory filings with FDA and international agencies.